Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Biochimie ; 75(1-2): 127-34, 1993.
Artigo em Inglês | MEDLINE | ID: mdl-7684932

RESUMO

A recombinant homodimer p66/p66 of the HIV-1 reverse transcriptase (RT) was expressed in and purified from a protease-deficient strain of the yeast Saccharomyces cerevisiae. The RNase H activity associated with the homodimer was biochemically characterized. The effect of cations and the hybrid substrate specificity were studied. Some compounds which have been found to inhibit retroviral replication were tested as potential inhibitors of the retroviral DNA polymerase and RNase H activities. Most of these compounds inhibited preferentially the DNA polymerase activity. On the other hand, only suramin was found to inhibit RNase H more efficiently than DNA polymerase. As in the case of the DNA polymerase activity, the thiol-reacting agent N-ethylmaleimide (NEM) did not affect the RNAse H activity of HIV RT. When the effect of NEM was tested against E coli RNase H, a weak inhibitory effect was detected. Surprisingly, NEM strongly inhibits the same bacterial RNase H in the presence of a recombinant form of HIV RT devoid of nuclease activity. These results strongly suggest an interaction between E coli RNase H and HIV-1 RT.


Assuntos
Etilmaleimida/farmacologia , HIV-1 , Inibidores da Síntese de Ácido Nucleico , DNA Polimerase Dirigida por RNA/metabolismo , Ribonuclease H/metabolismo , Benzodiazepinas/farmacologia , Biopolímeros , Transcriptase Reversa do HIV , Imidazóis/farmacologia , Ácido Fosfonoacéticos/farmacologia , Fosfato de Piridoxal/farmacologia , DNA Polimerase Dirigida por RNA/efeitos dos fármacos , Proteínas Recombinantes/efeitos dos fármacos , Proteínas Recombinantes/metabolismo , Inibidores da Transcriptase Reversa , Ribonuclease H/antagonistas & inibidores , Ribonuclease H/química , Ribonuclease H/efeitos dos fármacos , Suramina/farmacologia
2.
N Biotechnol ; 29(3): 285-92, 2012 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-21807127

RESUMO

Moloney murine leukemia virus reverse transcriptase (M-MuLV RT) is a domain structured enzyme that has the N-terminally located DNA polymerization activity and C-terminally located RNase H activity, which interferes with the efficient synthesis of long cDNA molecules. Here we present the PEGylation as a tool for engineering the M-MuLV RT derivative deficient in RNase H activity. We demonstrate that site-directed chemical modification (SDCM) of the RNase H domain by selectively PEGylating C635, one of the eight cysteine residues present in the reverse transcriptase (RT), specifically inactivated its ribonucleolytic activity. As a consequence, the efficiency of long cDNA molecules synthesis by modified enzyme was greatly increased.


Assuntos
DNA Complementar/biossíntese , Vírus da Leucemia Murina de Moloney/química , Polietilenoglicóis/química , DNA Polimerase Dirigida por RNA/química , Transcrição Reversa , Ribonuclease H/química , Animais , DNA Complementar/química , Camundongos , Estrutura Terciária de Proteína , Ribonuclease H/antagonistas & inibidores
3.
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA